| 192.07 Delayed Data As of Dec 14 |  -5.46 / -2.76%Today’s Change | 163.31 Today|||52-Week Range 210.19 | +10.45% Year-to-Date |
| 5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019 Dec 14 / Zacks.com - Paid Partner Content | Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend Dec 10 / Zacks.com - Paid Partner Content |
| 5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride Dec 14 / Zacks.com - Paid Partner Content | Amgen Increases Quarterly Dividend Dec 09 / GuruFocus News - Paid Partner Content |
| Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Dec 13 / Zacks.com - Paid Partner Content | Biotech Stock Roundup: ASH Meet in Focus, Gilead's Drugs Get Approval in China Dec 05 / Zacks.com - Paid Partner Content |
| Amgen (AMGN) Gains But Lags Market: What You Should Know Dec 12 / Zacks.com - Paid Partner Content | Roche's Tecentriq Combination Gets Priority Review by FDA Dec 05 / Zacks.com - Paid Partner Content |
| Has Celgene Entered Bargain Territory? Dec 11 / GuruFocus News - Paid Partner Content | Amgen's BiTE Immunotherapies Show Promise in Early Studies Dec 04 / Zacks.com - Paid Partner Content |
| Previous close | 197.53 |
| Today’s open | 195.04 |
| Day’s range | 191.66 - 196.15 |
| Volume | 2,981,307 |
| Average volume (3 months) | 2,724,093 |
| Market cap | $122.8B |
| Earnings growth (last year) | -73.74% |
| Earnings growth (this year) | +13.23% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +0.45% |
| P/E ratio | 50.0 |
| Price/Sales | 5.61 |
| Price/Book | 5.52 |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -1.78 | -2.64% |
| BIIBBiogen | -5.59 | -1.75% |
| ILMNIllumina Inc | -8.16 | -2.44% |
| TLRYTilray Inc | -0.39 | -0.52% |
| Next reporting date | January 29, 2019 |
| EPS forecast (this quarter) | $3.27 |
| Annual revenue (last year) | $22.8B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 8.69% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert A. Bradway |
Executive Vice President- Operations Esteban Santos |
Corporate headquarters Thousand Oaks, California |
